Profile: Daniel E Troy

Life Sciences

Biography: Life Sciences

Daniel Troy, a partner in Sidley's life sciences practice as well its appellate litigation group, is the former chief counsel of the Food and Drug Administration (FDA). In addition to providing strategic counselling on FDA-related matters, Mr Troy practises administrative and constitutional law and litigation, with particular focus on the industries regulated by the FDA.

Mr Troy headed the ABA's section of administrative law and regulatory practice from 2006 to 2007 and was the first appointee to the FDA made by President George W Bush. In that capacity, he reviewed and approved major regulations and important guidance issued during that time. He played a key role in the drafting of the rule modifying the process by which generic drugs come to market, and successfully argued two Hatch-Waxman cases for the FDA. He oversaw the agency's warning and untitled letters, helped raise the agency's focus on first amendment issues, and played a principal role in the FDA's generally successful assertion of pre-emption in selected product liability cases.

Before joining the FDA, Mr Troy regularly argued cases in federal and state courts of appeals, including a successful appearance before the United States Supreme Court in Vera v Bush, 517 US 952 (1996), the 14th amendment challenge to race-based redistricting plan.